Meticulous Research®, a premier global market research firm, has released a comprehensive report titled ‘Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (MAb, Vaccine), Research], End User - Global Forecast to 2030.’ According to this report, the single-use bioreactors market is projected to achieve $10.3 billion by 2030, with a compound annual growth rate (CAGR) of 15.8%. Key growth drivers include the increasing use of disposable technologies in the pharmaceutical and biotechnology sectors, expansion of biopharmaceutical manufacturing capacities, rising R&D investments, growing acceptance of biosimilars, and the increasing incidence of chronic diseases.

Market Segmentation and Future Outlook
The single-use bioreactors market is segmented by product, type, cell type, application, end user, and region.

Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5005

• Product: The market is categorized into single-use bioreactor systems, media bags (2D, 3D, linear), filtration assemblies, and other products. In 2023, single-use bioreactor systems are anticipated to dominate the market due to their advantages, including reduced cleaning requirements, smaller footprint, lower capital investment, enhanced flexibility, and minimized risk of cross-contamination.

• Type: Stirred-tank bioreactors are expected to lead the market in 2023, favored for their compatibility with CHO cell lines, suspension cultures, and large-volume bio-production while overcoming challenges associated with traditional designs.

• Cell Type: Mammalian cells are projected to hold the largest market share in 2023. This dominance is attributed to their critical role in both commercial and research bioproduction, including the development of complex biomolecules like monoclonal antibodies and therapeutic proteins.

• Application: The commercial bio-production segment is expected to be the largest in 2023, driven by the rising prevalence of chronic diseases, increased demand for biopharmaceuticals, and supportive regulatory reforms promoting biosimilars.

• End User: The segment comprising contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) is expected to grow at the highest rate during the forecast period. This growth is fueled by the outsourcing trends among pharmaceutical and biopharmaceutical companies, inorganic growth strategies, and expansion plans by CDMOs.

Geographic Insights
The report provides a detailed analysis of key regions: North America (U.S. and Canada), Europe (including Germany, France, U.K., Italy, Spain, Switzerland, Ireland, Denmark, Belgium, and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa. Europe is anticipated to hold the largest market share in 2023, attributed to increasing drug sales, supportive government and regulatory policies for biopharmaceuticals, and expansion of manufacturing capacities by various companies.

Quick Buy – Single-use Bioreactors Market- Global Opportunity Analysis And Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/67912642

Key Players
The report profiles leading companies in the single-use bioreactors market, including Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.), CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Distek, Inc. (U.S.), and Infors AG (Switzerland).

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research